StockData
Sunshine Biopharma Inc. logo

Sunshine Biopharma Inc. (SBFM) stock

SBFMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFMW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 10/30
$2.41−0.13 (-5.12%)

Close on Nov 18, 2026Market cap $9.34MP/E –Yield –

Sunshine Biopharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Sunshine Biopharma's price to sales ratio was 0.2× on Nov 11, 2026, against 35.4× a year earlier. Over the last 5 years it ranged from 0.0× to 101.7×, with a median of 21.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.2×−29.8
2025Dec 31, 202530.0×−6.4
2024Dec 31, 202436.4×+35.7
2023Dec 29, 20230.7×−48.6
2022Dec 30, 202249.2×+47.5
2021Dec 31, 20211.8×+0.7
2020Dec 31, 20201.1×+1.1
2019Aug 27, 20190.0×−0.0
2018Jul 10, 20180.0×−0.0
2016Jul 29, 20160.0×+0.0
2015Dec 31, 20150.0×–

More Sunshine Biopharma figures

See a number that looks wrong?